Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

M Lab Collaboration Center Shanghai (Merck)

In July 2020 Merck, a leading science and technology company, opened its M LabTM Collaboration Center in Shanghai, the company’s largest of nine centers worldwide. With a total lab size of approximately 10,000m2, Merck’s newest M Lab™ Collaboration Center is located in Pudong, at the heart of the biomedical sciences and research community in Shanghai. The new M Lab™ Collaboration Center in Shanghai offers customizable solutions tailored for China’s Life Science community to help advance drug development. It includes Pilot Scale and Process Development support labs that offer non-GMP (Good Manufacturing Practice) lab space where pharmaceutical and biopharmaceutical manufacturers can explore ideas, learn innovative techniques and work side-by-side with the company’s scientists and engineers to solve critical process development and production challenges. Customers can participate in product demonstrations, hands-on training, formal bioprocessing educational courses and experiments, as well as apply best practices and new approaches to develop, optimize and scale-up processes and simplify global technology transfer. Customers will also be able to tap into the following Merck offerings: > Lab Management Software: This digital platform helps scientists improve efficiency and processes by automating workflows and connecting lab instruments via the cloud. The software centralizes research information, allowing researchers to move away from transferring and documenting data by hand, increasing productivity and helping them to avoid costly errors. > Customized Cell Culture Media facility: This facility develops cell culture media, which are used in the production of biopharmaceuticals and will be used for non-GMP pilot production. > Solid Dose Formulation facility: This facility helps ensure drugs in tablet/capsule/powder form contain high quality excipients and active pharmaceutical ingredients. This facility will support customers in China and around the world. Additionally, the center will host a new BioReliance® End-to-End Solutions GMP manufacturing facility offering contract development manufacturing organization services to customers in China and Asia-Pacific. As a leading innovator in the pharmaceutical and biopharmaceutical industry, Merck is committed to playing an active role in China’s transformation into an innovation- driven economy. Through this new center, Merck will collaborate with local and regional customers to increase drug quality and safety and provide training and knowledge transfer. *

 

Period Start 2020-07-10 established
  Group Merck (DE) (Group)
Products Industry LIFE SCIENCES
  Industry 2 BioReliance® End-to-End Solutions
     
Region Region Shanghai
  Country China
  City n. a. Shanghai
    Address record changed: 2020-07-18
     
Basic data Employees n. a.
     
    * Document for �About Section�: Merck KGaA. (7/10/20). "Press Release: Merck Opens its Largest M Lab Collaboration Center in Shanghai". Darmstadt.
     
   
Record changed: 2020-07-18

Advertisement

Picture Berlin Partner Berlin-Brandenburg Healthcare Industries Cluster 650x80px

More documents for Merck (DE) (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group ChinaBio Partnerting Forum 2021 651x80




» top